Announcements Trials

Browse Landscape

Status

Recruiting 8 Completed 8 Unknown 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 3 Breast Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Tubular Adenocarcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Infections 1 Hemangioma, Cavernous, Central Nervous System 1 Hemangioma 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Gallbladder Cancer Unresectable 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Cancer-Related Condition 1 Cachexia 1 Brenner Tumor 1 Biliary Tract Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Observation × Clear all

NCT03789136 2021-06-29

COMUNEX

Wageningen University

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡